Patents by Inventor Mark E. Sobel

Mark E. Sobel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Kit for diagnosing cancer metastatic potential
    Patent number: 5049662
    Abstract: A new NM23 gene and its relationship with metastatic potential of tumor cells is described.
    Type: Grant
    Filed: October 13, 1987
    Date of Patent: September 17, 1991
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Patricia S. Steeg, Lance A. Liotta, Mark E. Sobel, Generoso Bevilacqua
  • Recombinant DNA clone encoding laminin receptor
    Patent number: 4861710
    Abstract: The invention provides a recombinant cDNA clone encoding cell surface receptor for laminin, as well as a probe and methods of using that probe to diagnose the aggressiveness of a carcinoma or the effectiveness of an agent for treating cancer cells.
    Type: Grant
    Filed: September 26, 1986
    Date of Patent: August 29, 1989
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Mark E. Sobel, Lance A. Liotta, Ulla M. Wewer, Michael C. Jaye, William N. Drohan
  • Gene for diagnosing cancer metastatic potential
    Patent number: RE35097
    Abstract: A new NM23 gene and its relationship with metastatic potential of tumor cells is described.
    Type: Grant
    Filed: April 6, 1993
    Date of Patent: November 21, 1995
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Patricia S. Steeg, Lance A. Liotta, Mark E. Sobel